ACHE and Alzheimer disease: As the present therapeutic strategy in AD patients is to restore function of cholinergic system via inhibiting AChE and consequently enhancing cholinergic neurotransmission, the activity of carvacrol in AChE inhibition appears to play a valuable role in cognitive function improvement (Azizi et al., 2012 ▶).